1. Home
  2. REGN vs CMG Comparison

REGN vs CMG Comparison

Compare REGN & CMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REGN
  • CMG
  • Stock Information
  • Founded
  • REGN 1988
  • CMG 1993
  • Country
  • REGN United States
  • CMG United States
  • Employees
  • REGN N/A
  • CMG N/A
  • Industry
  • REGN Biotechnology: Pharmaceutical Preparations
  • CMG Restaurants
  • Sector
  • REGN Health Care
  • CMG Consumer Discretionary
  • Exchange
  • REGN Nasdaq
  • CMG Nasdaq
  • Market Cap
  • REGN 59.5B
  • CMG 54.0B
  • IPO Year
  • REGN 1991
  • CMG 2006
  • Fundamental
  • Price
  • REGN $654.37
  • CMG $30.83
  • Analyst Decision
  • REGN Buy
  • CMG Buy
  • Analyst Count
  • REGN 21
  • CMG 28
  • Target Price
  • REGN $779.00
  • CMG $48.71
  • AVG Volume (30 Days)
  • REGN 1.0M
  • CMG 24.0M
  • Earning Date
  • REGN 10-28-2025
  • CMG 10-29-2025
  • Dividend Yield
  • REGN 0.55%
  • CMG N/A
  • EPS Growth
  • REGN 2.88
  • CMG 4.56
  • EPS
  • REGN 41.59
  • CMG 1.13
  • Revenue
  • REGN $14,247,800,000.00
  • CMG $11,787,400,000.00
  • Revenue This Year
  • REGN $1.34
  • CMG $6.75
  • Revenue Next Year
  • REGN $5.23
  • CMG $10.35
  • P/E Ratio
  • REGN $15.49
  • CMG $28.31
  • Revenue Growth
  • REGN 2.89
  • CMG 7.31
  • 52 Week Low
  • REGN $476.49
  • CMG $31.01
  • 52 Week High
  • REGN $844.51
  • CMG $66.74
  • Technical
  • Relative Strength Index (RSI)
  • REGN 67.60
  • CMG 19.59
  • Support Level
  • REGN $625.14
  • CMG $31.01
  • Resistance Level
  • REGN $664.00
  • CMG $32.29
  • Average True Range (ATR)
  • REGN 17.50
  • CMG 1.12
  • MACD
  • REGN 4.95
  • CMG -1.04
  • Stochastic Oscillator
  • REGN 89.45
  • CMG 0.67

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

About CMG Chipotle Mexican Grill Inc.

Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $11.3 billion in 2024. The Mexican concept is almost exclusively company-owned, with just three license stores operated through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of 3,726 stores at the end of 2024, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.

Share on Social Networks: